Brian Tycangco (in ”Asian Growth Stocks”) sees a tiny biotech company eliminating the need for insulin injections for diabetics. The company is also working on Parkinson’s and other ”un-touchable” diseases by developing the ability to insert foreign cells into a person’s body without an immune reaction. Is this one of those too-good-to-be-true speculations, or is it worth at least a small investment?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.